Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: an analysis from the italian pharmacovigilance database

HIGHLIGHTS

• who: Maria Antonietta Barbieri and collaborators from the Azienda Usl Toscana nord ovest, Italy Carol Davila University of Medicine have published the article: Safety profile of tyrosine kinase inhibitors used in non-small-cell lung cancer: An analysis from the Italian pharmacovigilance database, in the Journal: (JOURNAL) of December/31,/2021
• what: The aim of this study was to analyze the onset of adverse drug reactions (ADRs) related to TKIs in NSCLC through a spontaneous reporting system (SRS) database. The aim of this study was 1) to highlight all Italian open data-related ADRs associated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.